Physician profile
Tabitha G Saylor
NPI 1609266618
$3,252.94
in general payments reported to CMS, 2019-2025
14 companies · $99.90 in 2025
The $99.90 reported for 2025 was less than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,789 · 2022: $988 · 2023: $254 · 2024: $121 · 2025: $99.90.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $395 · Education: $79.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $395.10 |
| Education | $79.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Axonics, INC. | $1,879.45 | 2021-2023 | Axonics |
| Teleflex LLC | $558.90 | 2022 | |
| Abbvie INC. | $175.17 | 2022-2025 | |
| Urovant Sciences INC | $124.07 | 2022 | |
| Astellas Pharma US INC | $117.09 | 2021-2024 | Xtandi, Myrbetriq |
| Glaxosmithkline, LLC. | $116.10 | 2022 | |
| Janssen Biotech, INC. | $79.99 | 2023 | Erleada |
| Medtronic, INC. | $55.03 | 2021 | |
| Endo Pharmaceuticals INC. | $49.98 | 2023-2024 | Xiaflex |
| Boston Scientific Corporation | $25.44 | 2024 | Lynx System |
| Bayer Healthcare Pharmaceuticals INC. | $22.04 | 2023 | |
| Procept Biorobotics Corporation | $18.30 | 2024 | Aquabeam System |
| Sumitomo Pharma America, INC. | $17.16 | 2023 | Gemtesa |
| Olympus America INC. | $14.22 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tabitha Saylor listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.